Inotuzumab ozogamicin | 動物用藥查詢網
Inotuzumabozogamicin,soldunderthebrandnameBesponsa,isanantibody-drugconjugatemedicationusedtotreatrelapsedorrefractoryB-cellprecursor ...
Chemical compound
Inotuzumab ozogamicin, sold under the brand name Besponsa, is an antibody-drug conjugate medication used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia.[4][5] It is administered by intravenous infusion.[4][5]
The medication consists of a humanized monoclonal antibody against CD22 (inotuzumab), linked to a cytotoxic agent from the class of calicheamicins called ozogamicin.[6]
The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.[7]
Medical use[edit]Inotuzumab ozogamicin is used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia.[4][5]
In March 2024, the FDA approved inotuzumab ozogamicin for the treatment of children aged one year and older with relapsed or refractory CD22-positive B-cell precursor acute lymph...
ALL新藥inotuzumab ozogamicin獲健保給付 | 動物用藥查詢網
Inotuzumab ozogamicin | 動物用藥查詢網
Inotuzumab ozogamicin as single agent in pediatric patients ... | 動物用藥查詢網
Inotuzumab Ozogamicin for RelapsedRefractory ... | 動物用藥查詢網
Inotuzumab ozogamicin in the treatment of acute ... | 動物用藥查詢網
Inotuzumab ozogamicin with bosutinib for relapsed ... | 動物用藥查詢網
Inotuzumab Ozogamicin-成人急性淋巴性白血病治療新 ... | 動物用藥查詢網
Phase II Trial of Inotuzumab Ozogamicin in Children ... | 動物用藥查詢網
認識化療藥品Inotuzumab | 動物用藥查詢網
百利先24%注射劑 POLYCIDE 24% INJ.
百利先24%注射劑有哪些副作用?由公源藥品股份有限公司觀音廠製造的百利先24%注射劑是治療什麼的?藥品成分是什麼?以下為大...
百利先12%注射劑 POLYCIDE 12% INJ
百利先12%注射劑有哪些副作用?由公源藥品股份有限公司觀音廠製造的百利先12%注射劑是治療什麼的?藥品成分是什麼?以下為大...